Intercepting pancreatic cancer development with mutant KRAS-targeted immunotherapy

被引：2
|
作者：
Zaidi, Neeha
Huff, Amanda
Marcisak-Davis, Emily
Haldar, Daniel
Heumann, Thatcher
Konig, Max
Mog, Brian
Montagne, Janelle
Longway, Gabriella
Andaloori, Lalitya
Lyman, Melissa
Danilova, Ludmila
Nauroth, Julie
Kagohara, Luciane
Fertig, Elana
Azad, Nilo
Jaffee, Elizabeth
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 22期
关键词：
D O I：
10.1158/1538-7445.PANCA22-IA013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA013
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association of mutant KRAS isoforms with weight loss in pancreatic cancer
    Kim, Haesoo
    Ng, Camille
    Diniz, Marcio A.
    Montoril, Michel H.
    Guan, Michelle
    Brodsky, Victor
    Vail, Eric
    Tuli, Richard
    Blais, Edik
    Kim, Sungjin
    Petricoin, Emanuel, III
    Gong, Jun
    Placencio-Hickok, Veronica R.
    Hendifar, Andrew E.
    CANCER RESEARCH, 2019, 79 (24)
  • [32] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
    Kiaie, Seyed Hossein
    Sanaei, Mohammad Javad
    Heshmati, Masoud
    Asadzadeh, Zahra
    Azimi, Iman
    Hadidi, Saleh
    Jafari, Reza
    Baradaran, Behzad
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (05) : 1083 - 1097
  • [34] Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer
    Rocha, Flavio G.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1400 - 1406
  • [35] Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer
    Flavio G. Rocha
    Annals of Surgical Oncology, 2021, 28 : 1400 - 1406
  • [36] Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer
    Cao, Dujuan
    Song, Qianqian
    Li, Junqi
    Jiang, Yuanyuan
    Wang, Zhimin
    Lu, Shuangshuang
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2021, 23
  • [37] The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy
    Shu, Chun-Lu
    Liu, Yu -Ling
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3485 - 3492
  • [38] Spatial Heterogeneity of Mutant KRAS Expression in the Context of Pancreatic Cancer Subtypes
    不详
    PANCREAS, 2022, 51 (07) : 874 - 874
  • [39] Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer
    Pollin, Gareth
    Lomberk, Gwen A.
    Mathison, Angela J.
    Zimmermann, Michael T.
    Urrutia, Raul
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1996 - 2001
  • [40] Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe
    Real, Francisco X.
    de Andres, Monica P.
    TRENDS IN CANCER, 2018, 4 (06): : 399 - 401
12345